The Hydrogen Bond Environments of 1H-Tetrazole and Tetrazolate Rings: The Structural Basis for Tetrazole-Carboxylic Acid Bioisosterism

Bioisosterism involving replacement of a carboxylic acid substituent by 1H-tetrazole, yielding deprotonated carboxylate and tetrazolate under physiological conditions, is a well-known synthetic strategy in medicinal chemistry. To improve our overall understanding of bioisosterism, we have used this example to study the geometrical and energetic aspects of the functional group replacement. Specifically, we use crystal structure informatics and high-level ab initio calculations to study the hydrogen bond (H-bond) energy landscapes of the protonated and deprotonated bioisosteric pairs. Each pair exhibits very similar H-bond environments in crystal structures retrieved from the CSD, and the attractive energies of these H-bonds are also very similar. However, by comparison with -COOH and -COO(-), the H-bond environments around 1H-tetrazole and tetrazolate substituents extend further, by about 1.2 Å, from the core of the connected molecule. Analysis of pairs of PDB structures containing ligands which differ only in having a tetrazole or a carboxyl substituent and which are bound to the same protein indicates that the protein binding site must flex sufficiently to form strong H-bonds to either substituent. A survey of DrugBank shows a rather small number of tetrazole-containing drugs in the 'approved' and 'experimental' drug sections of that database.

[1]  N. Meanwell.  Synopsis of some recent tactical application of bioisosteres in drug design. , 2011, Journal of medicinal chemistry.

[2]  Gary Larson,et al.  Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[3]  S. B. Gates,et al.  Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases. , 2001, Journal of molecular biology.

[4]  Gary Larson,et al.  Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. , 2007, Bioorganic & medicinal chemistry letters.

[5]  Michael M. Hann,et al.  RECAP-Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry , 1998, J. Chem. Inf. Comput. Sci..

[6]  A. Moretto,et al.  Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site. , 2007, Journal of medicinal chemistry.

[7]  C. Thornber,et al.  Isosterism and molecular modification in drug design , 1979 .

[8]  T. Steiner.  Competition of hydrogen-bond acceptors for the strong carboxyl donor. , 2001, Acta crystallographica. Section B, Structural science.

[9]  Heming Xiao,et al.  First-principles study of electronic structure, absorption spectra, and thermodynamic properties of crystalline 1H-tetrazole and its substituted derivatives , 2010 .

[10]  Ian J Bruno,et al.  Bond lengths in organic and metal-organic compounds revisited: X-H bond lengths from neutron diffraction data. , 2010, Acta crystallographica. Section B, Structural science.

[11]  J. Bozzelli,et al.  Quantum chemical study of the structure and thermochemistry of the five-membered nitrogen-containing heterocycles and their anions and radicals. , 2006, The journal of physical chemistry. A.

[12]  Frank H. Allen,et al.  Hydrogen-bond directionality at the donor H atom—analysis of interaction energies and database statistics , 2009 .

[13]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[14]  Anthony J. Stone,et al.  An intermolecular perturbation theory for the region of moderate overlap , 1984 .

[15]  Robin Taylor,et al.  Use of crystallographic data in searching for isosteric replacements: Composite crystal-field environments of nitro and carbonyl groups† , 1990 .

[16]  Anthony J. Stone,et al.  Computation of charge-transfer energies by perturbation theory , 1993 .

[17]  C. Macrae,et al.  Mercury CSD 2.0 – new features for the visualization and investigation of crystal structures , 2008 .

[18]  Robin Taylor,et al.  Intermolecular Nonbonded Contact Distances in Organic Crystal Structures: Comparison with Distances Expected from van der Waals Radii , 1996 .

[19]  D. Joseph-McCarthy,et al.  Probing acid replacements of thiophene PTP1B inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[20]  Peter Ertl,et al.  Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..

[21]  Robin Taylor,et al.  Hydrogen bonding properties of oxygen and nitrogen acceptors in aromatic heterocycles , 1997 .

[22]  F. Allen.  The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.

[23]  A. Bondi.  van der Waals Volumes and Radii , 1964 .

[24]  F. H. Allen,et al.  A systematic pairwise comparison of geometric parameters obtained by X-ray and neutron diffraction , 1986 .

[25]  Jacqueline M Cole,et al.  Conformational variability of molecules in different crystal environments: a database study. , 2008, Acta crystallographica. Section B, Structural science.

[26]  Carl Henrik Görbitz,et al.  Hydrogen bonds to carboxylate groups. The question of three-centre interactions , 1992 .

[27]  Matthias Rarey,et al.  Recore: A Fast and Versatile Method for Scaffold Hopping Based on Small Molecule Crystal Structure Conformations , 2007, J. Chem. Inf. Model..

[28]  Olga Kennard,et al.  Hydrogen-bond geometry in organic crystals , 1984 .

[29]  J. Bajorath,et al.  Identification of target family directed bioisosteric replacements , 2011 .

[30]  H. A. Dabbagh,et al.  Density functional theory study of intermolecular interactions of cyclic tetrazole dimers , 2008 .

[31]  Carl Henrik Görbitz,et al.  Hydrogen bonds to carboxylate groups. Syn/anti distributions and steric effects , 1992 .

[32]  G. I. Koldobskii,et al.  Drugs in the tetrazole series. (Review) , 2007 .

[33]  W. Pitt,et al.  Heteroaromatic rings of the future. , 2009, Journal of medicinal chemistry.

[34]  Robin Taylor,et al.  IsoStar: A library of information about nonbonded interactions , 1997, J. Comput. Aided Mol. Des..

[35]  W. Price,et al.  Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. , 1991, Journal of medicinal chemistry.

[36]  C. Biot,et al.  5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials. , 2004, Journal of medicinal chemistry.

[37]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[38]  Robin Taylor,et al.  New software for searching the Cambridge Structural Database and visualizing crystal structures. , 2002, Acta crystallographica. Section B, Structural science.

[39]  R. J. Herr,et al.  5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods. , 2002, Bioorganic & medicinal chemistry.

[40]  T. Hudyma,et al.  Preparation and antiinflammatory properties of some 1-substituted 3-(5-tetrazolylmethyl)indoles and homologs. , 1969, Journal of medicinal chemistry.

[41]  Gerhard Klebe,et al.  Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions. , 2003, Journal of molecular biology.